Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Trinity Biotech Q4 Sales $19.52M Down From $32.77M YoY

Trinity Biotech (NASDAQ:TRIB) reported $19.52 million in sales this quarter. This is a 40.41 percent decrease over sales of $32.77 million the same period last year.
byBill Haddad
April 11, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Trinity Biotech (NASDAQ:TRIB) reported $19.52 million in sales this quarter. This is a 40.41 percent decrease over sales of $32.77 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

BTRS Holdings’s Earnings Outlook

By Benzinga Insights
Today, 2:55 AM
BTRS Holdings (NASDAQ:BTRS) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts estimate that BTRS Holdings will report an earnings per share (EPS) of $-0.08.

BTRS

Read More

Moderna Receives FDA Approval For Emergency Use Authorization Of 2nd Booster Dose Of Its COVID-19 Vaccine, mRNA-1273; Says 50 Μg Dose Approved For All Adults Over 50 Years Of Age And Immunocompromised Adults Over 18 Years Of Age

By Benzinga Newsdesk
Today, 2:55 AM
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for its

MRNA